Host genetic variation in the cell cycle and NF-κB pathways and overall survival in mantle cell lymphoma

被引：0
|
作者：
Habermann, Thomas M. [1 ]
Maurer, Matthew J. [1 ]
Wang, Sophia S. [2 ]
Morton, Lindsay M. [2 ]
Lynch, Charles F. [6 ]
Hartge, Patricia [2 ]
Cozen, Wendy [3 ]
Severson, Richard K. [5 ]
Scott, Davis [4 ]
Watson, David A. [1 ]
Chanock, Stephen J. [2 ]
Rothnnan, Nathamal [2 ]
Cerhan, James R. [1 ]
机构：
[1] Mayo Clin, Coll Med, Rochester, MN USA
[2] Natl Canc Inst, Bethesda, MD USA
[3] Univ So Calif, Los Angeles, CA USA
[4] Fred Hutchinson Canc Res Ctr, Seattle, WA USA
[5] Karmonas Canc Inst, Detroit, MI USA
[6] Univ Iowa, Iowa City, IA USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1582
引用
收藏
页码：472A / 473A
页数：2
相关论文
共 50 条
  • [1] Host genetic variation in tumor necrosis factor and nuclear factor-κB pathways and overall survival in mantle cell lymphoma: A discovery and replication study
    Wang, Yucai
    Habermann, Thomas M.
    Wang, Sophia S.
    Maurer, Matthew J.
    Sarangi, Vivekananda
    Link, Brian K.
    Feldman, Andrew L.
    Inwards, David J.
    Witzig, Thomas E.
    Cozen, Wendy
    Rothman, Nathaniel
    Asmann, Yan
    Slager, Susan L.
    Cerhan, James R.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (06) : E153 - E155
  • [2] Germline Variation in TNF and NF-Kappa B Pathways and Prognosis In Mantle Cell Lymphoma
    Habermann, Thomas M.
    Maurer, Matthew J.
    Link, Brian
    Macon, William R.
    Wang, Alice H.
    Inwards, David J.
    Witzig, Thomas E.
    Slager, Susan L.
    Cerhan, James R.
    BLOOD, 2010, 116 (21) : 1679 - 1680
  • [3] Inhibition of constitutive NF-κB activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis
    Pham, LV
    Tamayo, AT
    Yoshimura, LC
    Lo, P
    Ford, RJ
    JOURNAL OF IMMUNOLOGY, 2003, 171 (01): : 88 - 95
  • [4] NF-κB signaling and its relevance to the treatment of mantle cell lymphoma
    Swathi Balaji
    Makhdum Ahmed
    Elizabeth Lorence
    Fangfang Yan
    Krystle Nomie
    Michael Wang
    Journal of Hematology & Oncology, 11
  • [5] NF-κB signaling and its relevance to the treatment of mantle cell lymphoma
    Balaji, Swathi
    Ahmed, Makhdum
    Lorence, Elizabeth
    Yan, Fangfang
    Nomie, Krystle
    Wang, Michael
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [6] Bortezomib resistant constitutive NF-κB activation in mantle cell lymphoma
    Yang, David T.
    Young, Ken H.
    Kahl, Brad S.
    Miyamoto, Shigeki
    BLOOD, 2007, 110 (11) : 1015A - 1015A
  • [7] NF-κB and the cell cycle
    Ledoux, Adeline C.
    Perkins, Neil D.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2014, 42 : 76 - 81
  • [8] NF-κB PATHWAY ACTIVATION DETERMINES DRUG SENSITIVITY IN MANTLE CELL LYMPHOMA
    不详
    CANCER DISCOVERY, 2014, 4 (02) : 144 - 144
  • [9] CASEIN KINASE 1α, NF-κB, AND HUMAN LYMPHOMA CELL SURVIVAL
    Bidere, Nicolas
    ADVANCES IN TNF FAMILY RESEARCH, 2011, 691 : 661 - 661
  • [10] Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma
    Saba, Nakhle S.
    Liu, Delong
    Herman, Sarah E. M.
    Underbayev, Chingiz
    Tian, Xin
    Behrend, David
    Weniger, Marc A.
    Skarzynski, Martin
    Gyamfi, Jennifer
    Fontan, Lorena
    Melnick, Ari
    Grant, Cliona
    Roschewski, Mark
    Navarro, Alba
    Bea, Silvia
    Pittaluga, Stefania
    Dunleavy, Kieron
    Wilson, Wyndham H.
    Wiestner, Adrian
    BLOOD, 2016, 128 (01) : 82 - 92
12345